First oncology mAb biosimilar from Pfizer approved by FDA
US FDA approves Pfizer’s Trazimera, a biosimilar to Roche’s blockbuster product, Herceptin, for the treatment of HER2 positive breast cancer.
Archives for March 14, 2019
Cellectis to build CAR-T manufacturing sites in US and Europe
In a step towards the commercialisation of its ‘off-the-shelf’ CAR-T therapies, Cellectis begins construction of a facility in France and enters lease agreement for US facility.